CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

sterculia gum

Botanicalexperimental

Gum karaya or gum sterculia, also known as Indian gum tragacanth, is a vegetable gum produced as an exudate by trees of the genus Sterculia. Chemically, gum karaya is an acid polysaccharide composed of the sugars galactose, rhamnose and galacturonic acid. It is used as a thickener and emulsifier in foods, as a laxative, and as a denture adhesive. It is also used to adulterate Gum tragacanth due to their similar physical characteristics. As a food additive it has E number E416. — Wikipedia

Clinical trial activity

18 trials · 32 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
1

Earliest trial started Jul 31, 2012 (NCT01471522)

Timeline

2020s

  1. Jan 1, 2024

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07195656N/ASep 30, 2025FemPulse Corporation
NCT06971172N/AJun 1, 2025Cairo University
NCT06946979N/AApr 30, 2025Zhejiang Chinese Medical University
NCT06883864N/AApr 1, 2025Abbott, Capital Medical University
NCT06693934N/ANov 30, 2024Asia Diabetes Foundation, Chinese University of Hong Kong
NCT06299514N/AApr 25, 2024University of Western Ontario
NCT07016451Early Phase 1 (Phase 1)Apr 2, 2024Mahidol University
NCT06377826N/AApr 1, 2024Riphah International University
NCT06261801N/AFeb 7, 2024Hangzhou Third Hospital, Zhejiang University
NCT06101368N/AJan 1, 2024Health Education Research Foundation (HERF), University of Hail
NCT05480566N/AJun 1, 2022Hasselt University
NCT04594226N/ANov 30, 2020Lishui Hospital of Traditional Chinese Medicine, Zhejiang University
NCT04489641N/AJan 16, 2020Universidad de Cordoba
NCT04621097N/ADec 15, 2018Cairo University
NCT03215017N/AMay 15, 2017Karolinska Institute
NCT03558256N/AMay 16, 2016Jiao Tong University
NCT01985360Phase 4Jan 31, 2014Columbia University, Duke University, National Heart, Lung, and Blood Institute (NHLBI), New York University, Stanford University
NCT01471522N/AJul 31, 2012Cedars-Sinai Medical Center, Columbia University, Duke University, East Carolina University, Emory University, Harvard University, National Heart, Lung, and Blood Institute (NHLBI), New York University, Stanford University, University of British Columbia, University of Missouri, Kansas City, University of Montreal, Vanderbilt University
Showing 18 of 18 trials
Page 1 / 1

Organizations

Research & Development (32)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Cairo UniversityAcademic/Hospital2212018
Columbia UniversityAcademic/Hospital2022012
Duke UniversityAcademic/Hospital2022012
National Heart, Lung, and Blood Institute (NHLBI)Government2022012
New York UniversityAcademic/Hospital2222012
Stanford UniversityAcademic/Hospital2022012
Zhejiang UniversityAcademic/Hospital2112020
AbbottFor profit1012025
Asia Diabetes FoundationAcademic/Hospital1112024
Capital Medical UniversityAcademic/Hospital1112025
Cedars-Sinai Medical CenterAcademic/Hospital1012012
Chinese University of Hong KongAcademic/Hospital1012024
East Carolina UniversityAcademic/Hospital1012012
Emory UniversityAcademic/Hospital1012012
FemPulse CorporationFor profit1112025
Hangzhou Third HospitalAcademic/Hospital1112024
Harvard UniversityAcademic/Hospital1012012
Hasselt UniversityAcademic/Hospital1112022
Health Education Research Foundation (HERF)Academic/Hospital1112024
Jiao Tong UniversityAcademic/Hospital1112016
32 organizations
Page 1 / 2